251 related articles for article (PubMed ID: 32133483)
1. Monoamine Oxidase A Hypomethylation in Obsessive-Compulsive Disorder: Reversibility By Successful Psychotherapy?
Schiele MA; Thiel C; Deckert J; Zaudig M; Berberich G; Domschke K
Int J Neuropsychopharmacol; 2020 May; 23(5):319-323. PubMed ID: 32133483
[TBL] [Abstract][Full Text] [Related]
2. MAOA gene hypomethylation in panic disorder-reversibility of an epigenetic risk pattern by psychotherapy.
Ziegler C; Richter J; Mahr M; Gajewska A; Schiele MA; Gehrmann A; Schmidt B; Lesch KP; Lang T; Helbig-Lang S; Pauli P; Kircher T; Reif A; Rief W; Vossbeck-Elsebusch AN; Arolt V; Wittchen HU; Hamm AO; Deckert J; Domschke K
Transl Psychiatry; 2016 Apr; 6(4):e773. PubMed ID: 27045843
[TBL] [Abstract][Full Text] [Related]
3. Serotonin transporter gene promoter hypomethylation in obsessive-compulsive disorder - Predictor of impaired response to exposure treatment?
Schiele MA; Thiel C; Weidner M; Endres D; Zaudig M; Berberich G; Domschke K
J Psychiatr Res; 2021 Jan; 132():18-22. PubMed ID: 33035761
[TBL] [Abstract][Full Text] [Related]
4. Oxytocin Receptor Gene DNA Methylation: A Biomarker of Treatment Response in Obsessive-Compulsive Disorder?
Schiele MA; Thiel C; Kollert L; Fürst L; Putschin L; Kehle R; Hauke W; Mahr M; Reinhold E; Gottschalk MG; Heinrichs M; Zaudig M; Berberich G; Domschke K
Psychother Psychosom; 2021; 90(1):57-63. PubMed ID: 32920561
[TBL] [Abstract][Full Text] [Related]
5. Monoamine oxidase A gene DNA hypomethylation - a risk factor for panic disorder?
Domschke K; Tidow N; Kuithan H; Schwarte K; Klauke B; Ambrée O; Reif A; Schmidt H; Arolt V; Kersting A; Zwanzger P; Deckert J
Int J Neuropsychopharmacol; 2012 Oct; 15(9):1217-28. PubMed ID: 22436428
[TBL] [Abstract][Full Text] [Related]
6. Plasticity of Functional MAOA Gene Methylation in Acrophobia.
Schiele MA; Ziegler C; Kollert L; Katzorke A; Schartner C; Busch Y; Gromer D; Reif A; Pauli P; Deckert J; Herrmann MJ; Domschke K
Int J Neuropsychopharmacol; 2018 Sep; 21(9):822-827. PubMed ID: 30169842
[TBL] [Abstract][Full Text] [Related]
7. Modification of the association between early adversity and obsessive-compulsive disorder by polymorphisms in the MAOA, MAOB and COMT genes.
McGregor NW; Hemmings SMJ; Erdman L; Calmarza-Font I; Stein DJ; Lochner C
Psychiatry Res; 2016 Dec; 246():527-532. PubMed ID: 27821364
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA
JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832
[TBL] [Abstract][Full Text] [Related]
9. Combining genetic and epigenetic parameters of the serotonin transporter gene in obsessive-compulsive disorder.
Grünblatt E; Marinova Z; Roth A; Gardini E; Ball J; Geissler J; Wojdacz TK; Romanos M; Walitza S
J Psychiatr Res; 2018 Jan; 96():209-217. PubMed ID: 29102815
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic signature of MAOA and MAOB genes in mental disorders.
Ziegler C; Domschke K
J Neural Transm (Vienna); 2018 Nov; 125(11):1581-1588. PubMed ID: 30242487
[TBL] [Abstract][Full Text] [Related]
11. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder.
Karayiorgou M; Sobin C; Blundell ML; Galke BL; Malinova L; Goldberg P; Ott J; Gogos JA
Biol Psychiatry; 1999 May; 45(9):1178-89. PubMed ID: 10331110
[TBL] [Abstract][Full Text] [Related]
12. The effects of cognitive behavioral therapy on the whole brain structural connectome in unmedicated patients with obsessive-compulsive disorder.
Cao R; Yang X; Luo J; Wang P; Meng F; Xia M; He Y; Zhao T; Li Z
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110037. PubMed ID: 32682876
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic evidence for involvement of the oxytocin receptor gene in obsessive-compulsive disorder.
Cappi C; Diniz JB; Requena GL; Lourenço T; Lisboa BC; Batistuzzo MC; Marques AH; Hoexter MQ; Pereira CA; Miguel EC; Brentani H
BMC Neurosci; 2016 Nov; 17(1):79. PubMed ID: 27903255
[TBL] [Abstract][Full Text] [Related]
14. Reduced DNA methylation of the oxytocin receptor gene is associated with obsessive-compulsive disorder.
Park CI; Kim HW; Jeon S; Kang JI; Kim SJ
Clin Epigenetics; 2020 Jul; 12(1):101. PubMed ID: 32631409
[TBL] [Abstract][Full Text] [Related]
15. Low intensity technology-delivered cognitive behavioral therapy for obsessive-compulsive disorder: a meta-analysis.
Hoppen LM; Kuck N; Bürkner PC; Karin E; Wootton BM; Buhlmann U
BMC Psychiatry; 2021 Jun; 21(1):322. PubMed ID: 34193113
[TBL] [Abstract][Full Text] [Related]
16. Mindfulness-based cognitive therapy (MBCT) in patients with obsessive-compulsive disorder (OCD) and residual symptoms after cognitive behavioral therapy (CBT): a randomized controlled trial.
Külz AK; Landmann S; Cludius B; Rose N; Heidenreich T; Jelinek L; Alsleben H; Wahl K; Philipsen A; Voderholzer U; Maier JG; Moritz S
Eur Arch Psychiatry Clin Neurosci; 2019 Mar; 269(2):223-233. PubMed ID: 30446822
[TBL] [Abstract][Full Text] [Related]
17. A study of cognitive function in treatment-refractory obsessive-compulsive disorder treated with capsulotomy.
Gong F; Li P; Li B; Zhang S; Zhang X; Yang S; Liu H; Wang W
J Neurosurg; 2018 Feb; 128(2):583-595. PubMed ID: 28338440
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of cognitive behavioural therapy with medication for patients with obsessive-compulsive disorder: A multicentre randomised controlled trial in China.
Meng FQ; Han HY; Luo J; Liu J; Liu ZR; Tang Y; Hou X; Wei J; Shi LL; Tang MN; Yan YP; Huang YQ; Sun J; Li ZJ
J Affect Disord; 2019 Jun; 253():184-192. PubMed ID: 31108379
[TBL] [Abstract][Full Text] [Related]
19. Hoarding in children and adolescents with obsessive-compulsive disorder: prevalence, clinical correlates, and cognitive behavioral therapy outcome.
Højgaard DRMA; Skarphedinsson G; Ivarsson T; Weidle B; Nissen JB; Hybel KA; Torp NC; Melin K; Thomsen PH
Eur Child Adolesc Psychiatry; 2019 Aug; 28(8):1097-1106. PubMed ID: 30656432
[TBL] [Abstract][Full Text] [Related]
20. Adding motivational interviewing and thought mapping to cognitive-behavioral group therapy: results from a randomized clinical trial.
Meyer E; Shavitt RG; Leukefeld C; Heldt E; Souza FP; Knapp P; Cordioli AV
Braz J Psychiatry; 2010 Mar; 32(1):20-9. PubMed ID: 20339731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
